Evidence shows that pretreatment with PPAR-α agonist, clofibrate, can reduce the experimental myocardial infarct size up to 43% in rats [32], and it is well established that cardiac infarction and ischemia can cause the most types of arrhythmias. Here, PPARA is linked to myocardial infarction.